Risk factors of pacing-induced cardiomyopathy-Insights from lead position

Tomotaka Yoshiyama1, Kenji Shimeno2, Yusuke Hayashi2

  • 1Department of Cardiovascular Medicine Osaka City University Graduate School of Medicine Osaka Japan.

Insights

Right ventricular pacing did not significantly differ in causing pacing-induced cardiomyopathy (PICM) compared to mid-right ventricular septum pacing. Preoperative left ventricular size and paced QRS duration predicted PICM development.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Heart Failure

Background:

  • Pacing-induced cardiomyopathy (PICM) is a concern with long-term cardiac pacing.
  • The optimal lead placement to minimize PICM risk remains debated.
  • Right ventricular apex pacing is common but may be associated with adverse remodeling.

Purpose of the Study:

  • To compare the incidence of PICM between right ventricular apex pacing and mid-right ventricular septum pacing.
  • To identify predictors of PICM in patients undergoing pacemaker implantation.

Main Methods:

  • A comparative study design was employed.
  • Patients were divided into two groups based on pacing lead location: right ventricular apex and mid-right ventricular septum.
  • Incidence of PICM was assessed, and potential predictors including preoperative left ventricular end-systolic diameter and paced QRS duration were analyzed.

Main Results:

  • No significant difference in the incidence of pacing-induced cardiomyopathy was observed between the right ventricular apex pacing group and the mid-right ventricular septum pacing group.
  • Preoperative left ventricular end-systolic diameter was identified as an independent predictor of PICM.
  • Paced QRS duration was also found to be an independent predictor of PICM.

Conclusions:

  • Lead placement at the right ventricular apex versus the mid-right ventricular septum does not significantly alter the risk of developing pacing-induced cardiomyopathy.
  • Left ventricular end-systolic diameter and paced QRS duration are crucial factors to consider for predicting PICM development.
  • Further research may explore alternative pacing strategies or patient-specific factors influencing PICM.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
43
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
48
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
20
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
37
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.1K
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
6.7K